The largest database of trusted experimental protocols

5 protocols using dantrolene

1

Pharmacological Modulators of Neuronal Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following drugs were used in the present study: the NK1R agonist GR73632 (Sakurada et al., 1999 (link)), PI3K-Akt pathway inhibitor LY294002 (Xiao et al., 2018 (link)), PKC inhibitors chelerythrine and GF109203X (Cho et al., 2001 (link)) (the latter more selectively targets PKCα/β (Asehnoune et al., 2005 (link))), and store-operated Ca2+ entry (SOCE) inhibitors YM-58483 and MRS-1845 were purchased from Tocris, Minneapolis, MN. CaMKII inhibitor KN93, ERK1/2 pathway inhibitor U0126 were obtained from Calbiochem, San Diego, CA. The L-type Ca2+ channel blocker nifedipine was from Sigma/RBI (St. Louis, MO). The ryanodine receptor antagonist dantrolene, the inositol-1, 4, 5-triphosphate receptor (IP3R) antagonist 2-APB were purchased from Santa Cruz (Dallas,Texas). The 5-HT3 receptor antagonist palonosetron and NK1 receptor antagonist netupitant were kindly provided by Helsinn Health Care (Lugano, Switzerland). GR73632 and palonosetron were dissolved in water. Nifedipine, dantrolene, 2-APB, YM-58483, MRS-1845, U0126, LY294002, chelerythrine and GF109203X were dissolved in 25% DMSO in water. Netupitant was dissolved in a 1:1:18 solution of emulphor™, ethanol and saline. All drugs were administered at a volume of 0.1 ml/10 g of body weight.
+ Open protocol
+ Expand
2

Solvent Preparation for Pharmacological Agents

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following drugs were used in the present studies: ZD7288, U0126, MRS 1845, Z944 and RTX were purchased from Tocris (Ellisville, MO); ivabradine hydrochloride, nifedipine and sulpride from Sigma/RBI (St. Louis, MO); dantrolene and 2-APB from Santa Cruz Biotechnology (Dallas, TX). Palonosetron and netupitant were kindly provided by Helsinn Health Care (Lugano, Switzerland).
ZD7288, ivabradine hydrochloride and palonosetron were dissolved in water. Nifedipine, U0126, MRS 1845, Z944, dantrolene and 2-APB were dissolved in 25% DMSO in water. Netupitant and RTX were dissolved in a mixture of ethanol/Tween 80/saline at a volume ratio of 1:1:18. Sulpride was dissolved in distilled water with a 10 µL volume of 1/3 concentrated HCl which was then back titrated to pH 5 by the addition of NaOH. All drugs were administered at a volume of 0.1 ml/10 g of body weight.
+ Open protocol
+ Expand
3

Pharmacological Modulators of Cellular Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following drugs were used: m-3M3FBS, U73122, U0126, GF109203X, FPL64176, 2-methyl-serotonin maleate salt (2-Methyl-5-HT), and GR73632 were purchased from Tocris (Minneapolis, MN); McN-A-343, quinpirole HCl and nifedipine from Sigma Sigma/RBI (St. Louis, MO); thapsigargin, dantrolene and 2-APB from Santa Cruz Biotechnology (Dallas, TX). Palonosetron and netupitant were kindly provided by Helsinn Health Care (Lugano, Switzerland). m-3M3FBS, U73122, nifedipine, U0126, netupitant were dissolved in a mixture of ethanol/Tween 80/saline at a volume ratio of 1:1:18. dantrolene, 2-APB, GF109203X and FPL64176 were dissolved in 25% DMSO in water. thapsigargin was dissolved in 10% DMSO in distilled water. Other drugs were dissolved in distilled water. All drugs were administered at a volume of 0.1 ml/10 g of body weight.
+ Open protocol
+ Expand
4

Pharmacological Inhibition of Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following drugs were used for the present studies: FPL64176 from Tocris Bioscience (Minneapolis, MN), LTCC inhibitor nifedipine from Sigma (St. Louis, MO), RyR antagonist dantrolene, and IP3R antagonist 2-APB from Santa Cruz (Dallas, TX), PI3K-Akt pathway inhibitor LY294002 and PKC inhibitor GF109203X from Tocris (Minneapolis, MN), MEK-ERK inhibitor PD98059 from Calbiochem (San Diego, CA). PD98059 inhibits MEK and therefore phosphorylation of ERK (Hotokezaka et al., 2002 (link)). 5-HT3R antagonist palonosetron and NK1R antagonist netupitant were kindly provided by Helsinn Health Care (Lugano, Switzerland). Palonosetron was dissolved in water, FPL64176, nifedipine, dantrolene, 2-APB, PD98059, LY294002, GF109203X in 25% DMSO in water and netupitant was dissolved in a 1:1:18 solution of emulphor, ethanol and saline. All drugs were administered at a volume of 0.1 ml/10 g of body weight.
+ Open protocol
+ Expand
5

Pharmacological Modulation of Serotonin Receptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
2-Methylserotonin maleate salt (2-Me-5-HT) was purchased from Sigma/RBI (St. Louis, MO). Palonosetron was a generous gift from Helsinn Health Care (Lugano, Switzerland). The 5-HT2A receptor antagonist SR46349B was purchased from Sanofi (Bridgewater, NJ). The 5-HT6 receptor antagonists Ro-046790 and Ro-4368554 were purchased from Sigma/RBI (St. Louis, MO) and Tocris (Minneapolis, MN), respectively. The CaMKII inhibitor KN93 and its inactive analog KN92 as well as ERK1/2 inhibitor PD98059 were obtained from Calbiochem (San Diego, CA). The L-type Ca2+ channel antagonist amlodipine besylate was purchased from Tocris (Minneapolis, MN). The ryanodine receptor antagonist dantrolene (sodium salt) and the inositol-1, 4, 5-triphosphate receptor antagonist 2-APB, were obtained from Santa Cruz Biotechnology (Dallas, TX). Unless otherwise stated, the above drugs were dissolved in water. KN92, dantrolene sodium and 2-APB were dissolved in 25% DMSO in water. PD98059 was dissolved in 0.5% ethanol, 0.5% Tween-80 in saline. All drugs were administered at a volume of 0.1 ml/10 g of body weight.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!